Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity and IVF Success Rate in Patients Who Have Experienced IVF Failures.
Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 32
Maximum Age: 42
Healthy Volunteers: f
View:
• Agree to participate in the study
• 32-42 years old
• Having at least one previous embryo implantation failure
• History of low Embryo quality at day3 or day5 (according to Veeck's and Gardner's Criteria)
• No major uterine or ovarian abnormalities
• BMI level 18-25kg/m2
Locations
Other Locations
Japan
IVF Namba Clinic, Sankaky Medical Corporation
RECRUITING
Osaka
Contact Information
Primary
Udayanga KGS., Udayanga Gamage, BVSc, PhD
udayanga646@ivfjapan.com
+81 90 9823 8477
Backup
Masaya Y., Masaya Yamanaka, BSc
yamanaka086@ivfjapan.com
+81 80 4344 2654
Time Frame
Start Date: 2024-08-20
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 60
Treatments
Active_comparator: NMN intervention
NMN capsules (total of 900mg/day) for 8 weeks
Placebo_comparator: Placebo intervention
NMN-free placebo capsules for 8 weeks
Related Therapeutic Areas
Sponsors
Collaborators: Abinopharm, Inc, Aba Chemicals Co Ltd
Leads: Sunkaky Medical Cooperation